Morphology and Composition of the Inner Limiting Membrane: Species-Specific Variations and Relevance toward Drug Delivery Research

References

• Henrich PB, Monnier CA, Halfter W, Haritoglou C, Strauss RW, Lim RYH, Loparic M. Nanoscale topographic and biomechanical studies of the human internal limiting membrane. Invest Ophthalmol Vis Sci. 2012;53(6):2561–70. doi:10.1167/iovs.11-8502.
   PubMedGoogle Scholar
• Sebag J. Age-related differences in the human vitreoretinal interface. Arch Ophthalmol. 1991;109(7):966–71. doi:10.1001/archopht.1991.01080070078039.
   PubMedGoogle Scholar
• Müller H. Zur histologie der netzhaut. Zeitschrift für Wissenschaftlige Zoologie. 1851;3:234–37.
   Google Scholar
• Pedler C. The inner limting membrane of the retina. Br J Ophthalmol. 1961;45(6):423–38. doi:10.1136/bjo.45.6.423.
   PubMedGoogle Scholar
• Fine SB. Limiting membranes of the sensory pigment epithelium. Arch Ophthalmol. 1961;66:105–18. doi:10.1001/archopht.1961.00960010849012.
   Google Scholar
• Foos RY. Vitreoretinal juncture; topographical variations. Invest Ophthalmol. 1972;11:801–08.
   PubMedGoogle Scholar
• Masutani-Noda T, Yamada E. The mosaic pattern of the inner surface of vertebrate retina. Arch Histol Jpn. 1983;46(3):393–400. doi:10.1679/aohc.46.393.
   PubMedGoogle Scholar
• Rhodes RH. An ultrastructural study of complex carbohydrates in the posterior chamber and vitreous base of the mouse. Histochem J. 1985;17(3):291–312. doi:10.1007/BF01004592.
   PubMedGoogle Scholar
• Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye. 1992;6:541–52. doi:10.1038/eye.1992.119.
   PubMed Web of Science ®Google Scholar
• Halfter W, Sebag J, Emmet TC. Vitreoretinal interface and inner limiting membrane. In: Sebag J, editor. Vitreous: in health and disease. 1st ed. Springer-Verlag, New York; 2014. p. xxi–xxviii.
   Google Scholar
• Wollensak G, Spoerl E, Wirbelauer C, Pham DT. Influence of indocyanine green staining on the biomechanical strength of porcine internal limiting membrane. Ophthalmologica. 2004;218(4):278–82. doi:10.1159/000078621.
   PubMed Web of Science ®Google Scholar
• Peynshaert K, Devoldere J, De Smedt SC, Remaut K. In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye. Adv Drug Deliv Rev. 2018;126:44–57. doi:10.1016/j.addr.2017.09.007.
   PubMed Web of Science ®Google Scholar
• Balasubramani M, Schreiber EM, Candiello J, Balasubramani GK, Kurtz J, Halfter W. Molecular interactions in the retinal basement membrane system: A proteomic approach. Matrix Biol. 2010;29(6):471–83. doi:10.1016/j.matbio.2010.04.002.
   PubMed Web of Science ®Google Scholar
• Halfter W, Winzen U, Bishop PN, Eller A. Regulation of eye size by the retinal basement membrane and vitreous body. Investig Ophthalmol Vis Sci. 2006;47(8):3586–94. doi:10.1167/iovs.05-1480.
   PubMed Web of Science ®Google Scholar
• Uechi G, Sun Z, Schreiber EM, Halfter W, Balasubramani M. Proteomic view of basement membranes from human retinal blood vessels, inner limiting membranes, and lens capsules. J Proteome Res. 2014;13(8):3693–705. doi:10.1021/pr5002065.
   PubMed Web of Science ®Google Scholar
• Halfter W, Dong S, Balasubramani M, Bier ME. Temporary disruption of the retinal basal lamina and its effect on retinal histogenesis. Dev Biol. 2001;238(1):79–96. doi:10.1006/dbio.2001.0396.
   PubMed Web of Science ®Google Scholar
• Halfter W, Willem M, Mayer U. Basement membrane-dependent survival of retinal ganglion cells. Investig Ophthalmol Vis Sci. 2005;46(3):1000–09. doi:10.1167/iovs.04-1185.
   PubMed Web of Science ®Google Scholar
• Halfter W, Dong S, Schurer B, Ring C, Cole GJ, Eller A. Embryonic synthesis of the inner limiting membrane and vitreous body. Investig Ophthalmol Vis Sci. 2005;46(6):2202–09. doi:10.1167/iovs.04-1419.
   PubMed Web of Science ®Google Scholar
• Halfter W, Dong S, Dong A, Eller AW, Nischt R. Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body. Eye (Lond). 2008;22(10):1207–13. doi:10.1038/sj.eye.6702590.
   PubMed Web of Science ®Google Scholar
• Martin GR, Timpl R, Kühn K. Basement membrane proteins: molecular structure and function. Adv Protein Chem. 1988;39:1–50.
   PubMedGoogle Scholar
• Candiello J, Cole GJ, Halfter W. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol. 2010;29(5):402–10. doi:10.1016/j.matbio.2010.03.004.
   PubMed Web of Science ®Google Scholar
• Halfter W, Monnier C, Müller D, Oertle P, Uechi G, Balasubramani M, Safi F, Lim R, Loparic M, Henrich PB, et al. The bi-functional organization of human basement membranes. PLoS One. 2013;8(7):1–14. doi:10.1371/journal.pone.0067660.
   Web of Science ®Google Scholar
• Halfter W, Oertle P, Monnier CA, Camenzind L, Reyes-Lua M, Hu H, Candiello J, Labilloy A, Balasubramani M, Henrich PB, et al. New concepts in basement membrane biology. FEBS J. 2015;282(23):4466–79. doi:10.1111/febs.13495.
   PubMed Web of Science ®Google Scholar
• Mao M, Alavi MV, Labelle-Dumais C, Gould DB. Type IV collagens and basement membrane diseases: cell biology and pathogenic mechanisms. Vol. 76 Current Topics in Membranes Elsevier Ltd;2015. p. 61–116.
   Google Scholar
• Hohenester E, Yurchenco PD. Laminins in basement membrane assembly. Cell Adh Migr. 2013;7(1):56–63. doi:10.4161/cam.21831.
   PubMed Web of Science ®Google Scholar
• Yurchenco PD. Integrating activities of laminins that drive basement membrane assembly and function. Vol. 76 Current Topics in Membranes Elsevier Ltd;2015. p. 1–30 p.
   Google Scholar
• Battaglia C, Mayer U, Aumailley M, Timpl R. Basement‐membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur J Biochem. 1992;208(2):359–66. doi:10.1111/ejb.1992.208.issue-2.
   PubMedGoogle Scholar
• Aumailley M, Wiedemann H, Mann K, Timpl R. Binding of nidogen and the laminin nidogen complex to basement membrane collagen type IV. Eur J Biochem. 1989;184(1):241–48. doi:10.1111/ejb.1989.184.issue-1.
   PubMedGoogle Scholar
• Matsumoto B, Blanks JC, Ryan SJ. Topographic variation in the rabbit and primate internal limiting membrane. Invest Ophthalmol Vis Sci. 1984;25:71–82.
   PubMed Web of Science ®Google Scholar
• Malecaze F, Caratero C, Caratero A, Arne JL, Mathis A, Bee P, Planel H. Some ultrastructural aspects of the vitreoretinal juncture. Ophthalmologica. 1985;191(1):22–28. doi:10.1159/000309534.
   PubMed Web of Science ®Google Scholar
• Ponsioen TL, van Luyn MJA, van der Worp RJ, Pas HH, Hooymans JMM, Los LI. Human retinal Müller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol Vis. 2008;14:652–60.
   PubMed Web of Science ®Google Scholar
• Bu SC, Kuijer R, Van Der Worp RJ, Li XR, Hooymans JMM, Los LI. The ultrastructural localization of type II, IV, and VI collagens at the vitreoretinal interface. PLoS One. 2015;10(7):1–23. doi:10.1371/journal.pone.0134325.
   Web of Science ®Google Scholar
• Heegaard S. Structure of the human vitreoretinal border region. Ophthalmologica. 1994;208:82–92. doi:10.1159/000310458.
   PubMed Web of Science ®Google Scholar
• Syrbe S, Kuhrt H, Gärtner U, Habermann G, Wiedemann P, Bringmann A, Reichenbach A. Müller glial cells of the primate foveola: an electron microscopical study. Exp Eye Res. 2018;167:110–17. doi:10.1016/j.exer.2017.12.004.
   PubMed Web of Science ®Google Scholar
• Foos RY. Vitreoretinal juncture over retinal vessels. Albrecht von Graefes Archiv f?r Klinische und Experimentelle Ophthalmologie. 1977;204:223–34. doi:10.1007/BF00415316.
   PubMedGoogle Scholar
• Slijkerman RWN, Song F, Astuti GDN, Huynen MA, van Wijk E, Stieger K, Collin RWJ. The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies. Prog Retin Eye Res. 2015;48:137–59. doi:10.1016/j.preteyeres.2015.04.004.
   PubMed Web of Science ®Google Scholar
• Noulas AV, Skandalis SS, Feretis E, Theocharis DA, Karamanos NK. Variations in content and structure of glycosaminoglycans of the vitreous gel from different mammalian species. Biomed Chromatogr. 2004;18(7):457–61. doi:10.1002/bmc.340.
   PubMed Web of Science ®Google Scholar
• Pang JJ, Lauramore A, Deng WT, Li Q, Doyle TJ, Chiodo V, Li J, Hauswirth WW. Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration. Vision Res. 2008;48(3):377–85. doi:10.1016/j.visres.2008.06.005.
   PubMed Web of Science ®Google Scholar
• Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, Flannery JG. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009;17(12):2096–102. doi:10.1038/mt.2009.181.
   PubMed Web of Science ®Google Scholar
• Vacca O, Darche M, Schaffer DV, Flannery JG, Sahel JA, Rendon A, Dalkara D. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers. Glia. 2014;62(3):468–76. doi:10.1002/glia.v62.3.
   PubMed Web of Science ®Google Scholar
• Kolstad KD, Dalkara D, Guerin K, Visel M, Hoffmann N, Schaffer DV, Flannery JG. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. Hum Gene Ther. 2010;578(May):571–78. doi:10.1089/hum.2009.194.
   Web of Science ®Google Scholar
• Park TK, Wu Z, Kjellstrom S, Zeng Y, Bush RA, Sieving PA, Colosi P. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther. 2009;16(7):916–26. doi:10.1038/gt.2009.61.
   PubMed Web of Science ®Google Scholar
• Hellström M, Ruitenberg MJ, Pollett MA, Ehlert EME, Twisk J, Verhaagen J, Harvey AR. Cellular tropism and transduction properties of seven adeno-associated viral vector serotypes in adult retina after intravitreal injection. Gene Ther. 2009;16(4):521–32. doi:10.1038/gt.2008.178.
   PubMed Web of Science ®Google Scholar
• Yin L, Greenberg K, Hunter JJ, Dalkara D, Kolstad KD, Masella BD, Wolfe R, Visel M, Stone D, Libby RT, et al. Intravitreal injection of AAV2 transduces macaque inner retina. Investig Ophthalmol Vis Sci. 2011;52(5):2775–83. doi:10.1167/iovs.10-6250.
   PubMed Web of Science ®Google Scholar
• Mowat FM, Gornik KR, Dinculescu A, Boye SL, Hauswirth WW, Petersen-Jones SM, Bartoe JT. Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach. Gene Ther. 2014;21(1):96–105. doi:10.1038/gt.2013.64.
   PubMed Web of Science ®Google Scholar
• Aartsen WM, van Cleef KWR, Pellissier LP, Hoek RM, Vos RM, Blits B, Ehlert EME, Balaggan KS, Ali RR, Verhaagen J, et al. GFAP-driven GFP expression in activated mouse Müller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectors. PLoS One. 2010;5(8):1–12. doi:10.1371/journal.pone.0012387.
   Web of Science ®Google Scholar
• Ivanova E, Hwang GS, Pan ZH, Troilo D. Evaluation of AAV-mediated expression of chop2-GFP in the marmoset retina. Investig Ophthalmol Vis Sci. 2010;51(10):5288–96. doi:10.1167/iovs.10-5389.
   PubMed Web of Science ®Google Scholar
• Teo KYC, Lee SY, Barathi AV, Tun SBB, Tan L, Constable IJ. Surgical removal of internal limiting membrane and layering of AAV vector on the retina under air enhances gene transfection in a nonhuman primate. Investig Ophthalmol Vis Sci. 2018;59(8):3574–83. doi:10.1167/iovs.18-24333.
   PubMed Web of Science ®Google Scholar
• Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. 2,3 and 2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol. 2006;80(18):9093–103. doi:10.1128/JVI.00895-06.
   PubMed Web of Science ®Google Scholar
• Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol. 1998;72:1438–45.
   PubMed Web of Science ®Google Scholar
• Boye SL, Bennett A, Scalabrino ML, McCullough KT, Van Vliet K, Choudhury S, Ruan Q, Peterson J, Agbandje-McKenna M, Boye SE, et al. Impact of heparan sulfate binding on transduction of retina by recombinant adeno-associated virus vectors. J Virol. 2016;90(8):4215–31. doi:10.1128/JVI.00200-16.
   PubMed Web of Science ®Google Scholar
• Woodard KT, Liang KJ, Bennett WC, Samulski RJ. Heparan sulfate binding promotes accumulation of intravitreally-delivered adeno-associated viral vectors at the retina for enhanced transduction but weakly influences tropism. J Virol. 2016;90(21):9878–88. doi:10.1128/JVI.01568-16.
   PubMed Web of Science ®Google Scholar
• Sullivan JA, Stanek LM, Lukason MJ, Bu J, Osmond SR, Barry EA, O’Riordan CR, Shihabuddin LS, Cheng SH, Scaria A. Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Gene Ther. 2018;25(3):205–19. doi:10.1038/s41434-018-0017-8.
   PubMed Web of Science ®Google Scholar
• Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol. 2006;80(19):9831–36. doi:10.1128/JVI.00878-06.
   PubMed Web of Science ®Google Scholar
• Klimczak RR, Koerber JT, Dalkara D, Flannery JG, Schaffer DV. A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells. PLoS One. 2009;4(10). doi:10.1371/journal.pone.0007467.
   PubMed Web of Science ®Google Scholar
• Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5(189):189ra76. doi:10.1126/scitranslmed.3005708.
   PubMed Web of Science ®Google Scholar
• Hickey DG, Edwards TL, Barnard AR, Singh MS, De Silva SR, McClements ME, Flannery JG, Hankins MW, MacLaren RE. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina. Gene Ther. 2017;24(12):787–800. doi:10.1038/gt.2017.85.
   PubMed Web of Science ®Google Scholar
• Khabou H, Desrosiers M, Winckler C, Fouquet S, Auregan G, Bemelmans AP, Sahel JA, Dalkara D. Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant −7m8. Biotechnol Bioeng. 2016;113(12):2712–24. doi:10.1002/bit.25814.
   PubMed Web of Science ®Google Scholar
• Cehajic-Kapetanovic J, Milosavljevic N, Bedford RA, Lucas RJ, Bishop PN. Efficacy and safety of glycosidic enzymes for improved gene delivery to the retina following intravitreal injection in mice. Mol Ther - Methods Clin Dev. 2018;9(June):192–202. doi:10.1016/j.omtm.2017.12.002.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Igarashi T, Miyake K, Kobayashi M, Yaguchi C, Iijima O, Yamazaki Y, Katakai Y, Miyake N, Kameya S, et al. Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys. Mol Ther. 2017;25(1):296–302. doi:10.1016/j.ymthe.2016.10.004.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Ueno H, Goto Y, Oshima Y, Ishibashi T, Inomata H. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cells. Gene Ther. 1998;5(8):1088–97. doi:10.1038/sj.gt.3300591.
   PubMed Web of Science ®Google Scholar
• Tshilenge K-T, Ameline B, Weber M, Mendes-Madeira A, Nedellec S, Biget M, Provost N, Libeau L, Blouin V, Deschamps J-Y, et al. Vitrectomy before intravitreal injection of AAV2/2 vector promotes efficient transduction of retinal ganglion cells in dogs and nonhuman primates. Hum Gene Ther Methods. 2016;27(3):122–34. doi:10.1089/hgtb.2016.034.
   PubMed Web of Science ®Google Scholar
• Da Costa R, Röger C, Segelken J, Barben M, Grimm C, Neidhardt J. A novel method combining vitreous aspiration and intravitreal AAV2/8 injection results in retina-wide transduction in adult mice. Investig Ophthalmol Vis Sci. 2016;57(13):5326–34. doi:10.1167/iovs.16-19701.
   PubMed Web of Science ®Google Scholar
• Lee SH, Colosi P, Lee H, Ohn Y-H, Kim S-W, Kwak HW, Park TK. Laser photocoagulation enhances adeno-associated viral vector transduction of mouse retina. Hum Gene Ther Methods. 2014;25(1):83–91. doi:10.1089/hgtb.2013.089.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim YS, Nah SK, Kim HJ, Park HY, Yang JY, Park K, Park TK. Transduction patterns of adeno-associated viral vectors in a laser-induced choroidal neovascularization mouse model. Mol Ther - Methods Clin Dev. 2018;9(June):90–98. doi:10.1016/j.omtm.2018.01.008.
   PubMed Web of Science ®Google Scholar
• Boye SE, Alexander JJ, Witherspoon CD, Boye SL, Peterson JJ, Clark ME, Sandefer KJ, Girkin CA, Hauswirth WW, Gamlin PD, et al. Highly efficient delivery of AAV vectors to the primate retina. 2016;1(352):1–43.
   Google Scholar
• Stewart MW. Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF. Expert Rev Clin Pharmacol. 2014;7(2):167–80. doi:10.1586/17512433.2014.884458.
   PubMed Web of Science ®Google Scholar
• Mordenti J, Cuthbertson RA, Ferrara N, Thomsen K, Berleau L, Licko V, Allen PC, Valverde CR, Meng YG, Fei DT et al. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125 I-labeled full-length and fab antibodies following intravitreal administration. Toxicol Pathol. 1999;27(5):536–44. doi:10.1177/019262339902700507.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Spitznas M, Straatsma BR. Peroxidase diffusion in the normal and photocoagulated retina. Invest Ophthalmol Vis Sci. 1971;10:181–89.
   Google Scholar
• Takeuchi A, Kricorian G, Yao XY, Kenny JW, Marmor MF. The rate and source of albumin entry into saline-filled experimental retinal detachments. Investig Ophthalmol Vis Sci. 1994;35:3792–98.
   PubMed Web of Science ®Google Scholar
• Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128(6):739–46. doi:10.1016/S0002-9394(99)00239-1.
   PubMed Web of Science ®Google Scholar
• Lewis GP, Fisher SK, Anderson DH. Fate of biotinylated basic fibroblast growth factor in the retina following intravitreal injection. ExpEye Res. 1996;62:309–24.
   Google Scholar
• Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, Damico LA. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina. 2007;27(9):1260–66. doi:10.1097/IAE.0b013e318134eecd.
   PubMed Web of Science ®Google Scholar
• Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V. Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Investig Ophthalmol Vis Sci. 2005;46(2):726–33. doi:10.1167/iovs.04-0601.
   PubMed Web of Science ®Google Scholar
• Shahar J, Avery RL, Heilweil G, Barak A, Zemel E, Lewis GP, Johnson PT, Fisher SK, Perlman I, Loewenstein A. Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina. 2006;26(3):262–69. doi:10.1097/00006982-200603000-00002.
   PubMed Web of Science ®Google Scholar
• Pulido JS, Bakri SJ, Valyi-Nagy T, Shukla D. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina. 2007;27(8):1071–73. doi:10.1097/IAE.0b013e31804ac032.
   PubMed Web of Science ®Google Scholar
• Ekdawi NS, Pulido JS, Itty S, Marler RJ, Herman DC, Hardwig P, Mohney BG, Valyi-Nagy T, Shukla D. Intravitreal alemtuzumab penetrates full-thickness retina in rabbit eyes. Retina. 2009;29(10):1532–34. doi:10.1097/IAE.0b013e3181b901df.
   PubMed Web of Science ®Google Scholar
• Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, et al. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Investig Ophthalmol Vis Sci. 2007;48(6):2814–23. doi:10.1167/iovs.06-1171.
   PubMed Web of Science ®Google Scholar
• Dib E, Maia M, Longo-Maugeri IM, Martins MC, Mussalem JS, Squaiella CC, Penha FM, Magalha~Es O, Rodrigues EB, Farah ME. Subretinal bevacizumab detection after intravitreous injection in rabbits. Investig Ophthalmol Vis Sci. 2008;49(3):1097–100. doi:10.1167/iovs.07-1225.
   PubMed Web of Science ®Google Scholar
• Lassota N, Prause JU, Scherfig E, Kiilgaard JF, La Cour M. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization. Acta Ophthalmol. 2010;88(3):300–08. doi:10.1111/j.1755-3768.2008.01439.x.
   PubMed Web of Science ®Google Scholar
• Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina. 2011;31(2):393–400. doi:10.1097/IAE.0b013e3181e586b2.
   PubMed Web of Science ®Google Scholar
• Hutton-Smith LA, Gaffney EA, Byrne HM, Maini PK, Gadkar K, Mazer NA. Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model. Mol Pharm. 2017;14(8):2690–96. doi:10.1021/acs.molpharmaceut.7b00164.
   PubMed Web of Science ®Google Scholar
• Gadkar K, Pastuskovas CV, Le Couter JE, Elliott JM, Zhang J, Lee CV, Sanowar S, Fuh G, Kim HS, Lombana TN, et al. Design and pharmacokinetic characterization of novel antibody formats for ocular therapeutics. Investig Ophthalmol Vis Sci. 2015;56(9):5390–400. doi:10.1167/iovs.15-17108.
   PubMed Web of Science ®Google Scholar
• Li SK, Liddell MR, Wen H. Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis. J Pharm Biomed Anal. 2011;55(3):603–07. doi:10.1016/j.jpba.2010.12.027.
   PubMed Web of Science ®Google Scholar
• Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. Aaps J. 2004;6(3):article25. doi:10.1208/aapsj060322.
   Web of Science ®Google Scholar
• Apaolaza PS, Del Pozo-Rodríguez A, Solinís MA, Rodríguez JM, Friedrich U, Torrecilla J, Weber BHF, Rodríguez-Gascón A. Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles. Biomaterials. 2016;90:40–49. doi:10.1016/j.biomaterials.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Martens TF, Peynshaert K, Nascimento TL, Fattal E, Karlstetter M, Langmann T, Picaud S, Demeester J, De Smedt SC, Remaut K, et al. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy. Eur J Pharm Sci. 2017;103:27–35. doi:10.1016/j.ejps.2017.02.027.
   PubMed Web of Science ®Google Scholar
• Huang D, Chen YS, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina. Mol Pharm. 2017;14(2):533–45. doi:10.1021/acs.molpharmaceut.6b01029.
   PubMed Web of Science ®Google Scholar
• Kim H, Robinson SB, Csaky KG. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina. Pharm Res. 2009;26(2):329–37. doi:10.1007/s11095-008-9767-0.
   PubMed Web of Science ®Google Scholar
• Andrieu-Soler C, Aubert-Pouessel A, Doat M, Picaud S, Halhal M, Simonutti M, Venier-Julienne MC, Benoit JP and Behar-Cohen F et al. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis. 2005;11(February):1002–11.
   PubMed Web of Science ®Google Scholar
• Peters T, Kim S-W, Castro V, Stingl K, Strasser T, Bolz S, Schraermeyer U, Mihov G, Zong M, Andres-Guerrero V, et al. Evaluation of polyesteramide (PEA) and polyester (PLGA) microspheres as intravitreal drug delivery systems in albino rats. Biomaterials. 2017;124:157–68. doi:10.1016/j.biomaterials.2017.02.006.
   PubMed Web of Science ®Google Scholar
• Lee J, Goh U, Lee HJ, Kim J, Jeong M, Park JH. Effective retinal penetration of lipophilic and lipid-conjugated hydrophilic agents delivered by engineered liposomes. Mol Pharm. 2017;14(2):423–30. doi:10.1021/acs.molpharmaceut.6b00864.
   PubMed Web of Science ®Google Scholar
• Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, Woo SJ, Park KH, Chan Kwon I, Kim K, et al. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials. 2012;33(12):3485–93. doi:10.1016/j.biomaterials.2012.01.030.
   PubMed Web of Science ®Google Scholar
• Ochoa GP, Sesma JZ, Díez MA, Díaz-Tahoces A, Avilés-Trigeros M, Grijalvo S, Eritja R, Fernández E, Pedraz JL. A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina. Pharm Res. 2014;31(7):1665–75. doi:10.1007/s11095-013-1271-5.
   PubMed Web of Science ®Google Scholar
• Ojeda E, Puras G, Agirre M, Zarate J, Grijalvo S, Eritja R, Martinez-Navarrete G, Soto-Sánchez C, Diaz-Tahoces A, Aviles-Trigueros M, et al. The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain. Biomaterials. 2016;77:267–79. doi:10.1016/j.biomaterials.2015.11.017.
   PubMed Web of Science ®Google Scholar
• Mashal M, Attia N, Puras G, Martínez-Navarrete G, Fernández E, Pedraz JL. Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60. J Control Release. 2017;254(January):55–64. doi:10.1016/j.jconrel.2017.03.386.
   PubMed Web of Science ®Google Scholar
• Kim H, Csaky KG. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. J Control Release. 2010;142(2):286–93. doi:10.1016/j.jconrel.2009.11.006.
   PubMed Web of Science ®Google Scholar
• Nishihara H. Studies on the ultrastructure of the inner limiting membrane of the retina. I. Surface replication study on the inner limiting membrane of the retina. Nihon Ganka Gakkai Zasshi. 1989 Apr;93(4):429–38.
   PubMedGoogle Scholar
• Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Investig Ophthalmol Vis Sci. 2003;44(8):3562–69. doi:10.1167/iovs.02-1068.
   PubMed Web of Science ®Google Scholar
• Peynshaert K, Devoldere J, Forster V, Picaud S, De Smedt SC, Remaut K. Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface. Drug Deliv. 2017;24(1):1384–94. doi:10.1080/10717544.2016.1267822.
   PubMed Web of Science ®Google Scholar
• MacLaren RE, Bennett J, Schwartz SD. Gene therapy and stem cell transplantation in retinal disease: the new frontier. Ophthalmology. 2016;123(10):S98–106. doi:10.1016/j.ophtha.2016.06.041.
   PubMed Web of Science ®Google Scholar
• Johnson TV, Bull ND, Martin KR. Identification of barriers to retinal engraftment of transplanted stem cells. Investig Ophthalmol Vis Sci. 2010;51(2):960–70. doi:10.1167/iovs.09-3884.
   PubMed Web of Science ®Google Scholar
• Nishida A, Takahashi M, Tanihara H, Nakano I. Incorporation and differentiation of hippocampus- derived neural stem cells transplanted in injured adult rat retina AND. Invest Ophthalmol Vis Sci. 2000;41:4268–74.
   PubMed Web of Science ®Google Scholar
• Yu S, Tanabe T, Dezawa M, Ishikawa H, Yoshimura N. Effects of bone marrow stromal cell injection in an experimental glaucoma model. Biochem Biophys Res Commun. 2006;344(4):1071–79. doi:10.1016/j.bbrc.2006.04.003.
   PubMed Web of Science ®Google Scholar
• Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000;132(4):476–84. doi:10.1007/s002210000360.
   PubMed Web of Science ®Google Scholar
• Kim IB, Kim KY, Joo CK, Lee MY, Oh SJ, Chung JW, Chun MH. Reaction of Müller cells after increased intraocular pressure in the rat retina. Exp Brain Res. 1998;121(4):419–24. doi:10.1007/s002210050476.
   PubMed Web of Science ®Google Scholar
• Del Amo EM, Rimpelä AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 2017;57:134–85. doi:10.1016/j.preteyeres.2016.12.002.
   PubMed Web of Science ®Google Scholar